2050 Capital
Venture capitalLondon Β· Seed Β· 1 people tracked
Investment thesis
2050 Capital is a London-based early-stage venture firm investing in deep tech and science-driven companies, with a focus on enterprise software with a scientific component, computational biotech, and engineering ventures. It typically writes seed checks of $200-500k and follows on with up to $3m in later rounds, closing a small number of deals per year. The firm supports portfolio companies with business development, strategy, and subsequent fundraising.
Team Β· 1 people
from the firm's websiteFrequently asked questions
- What stage does 2050 Capital invest at?
- 2050 Capital invests at the Seed stage.
- What sectors does 2050 Capital focus on?
- 2050 Capital focuses on Biotech, Deep Tech, Enterprise Software.
- Where is 2050 Capital located?
- 2050 Capital is headquartered in London, GB.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.
